| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-27 | NCT07608159 Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06107920 | Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy | Colon Cancer | Recruiting |
| NCT07608159 | Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. | Non Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT07383818 | Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low… | HR Positive/HER2 Low Breast Cancer | Recruiting |
| NCT06290687 | Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative… | Malignant Neoplasm of Bladder | Recruiting |
| NCT07581405 | GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for… | Gastric Adenocarcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07217990 | Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of… | Breast Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT06386887 | Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer | Epithelial Ovarian Cancer | Recruiting |
| NCT07407244 | Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant… | Breast Cancer | Active, Not Recruiting |
| NCT07413146 | Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated… | Minimal Residual Disease | Not Yet Recruiting |
| NCT07570368 | Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance… | Breast Cancer | Not Yet Recruiting |